Azacitidine
NDC 43817-906, Azacitidine, injection, powder, lyophilized, for solution, from Panacea Biotec Limited.
- Product NDC
- 43817-906
- Status
- Listed
- Labeler
- Panacea Biotec Limited
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207234
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43817-906 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZACITIDINE100 mg/50mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43817-906-01 | 43817090601 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43817-906-01) / 50 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9abb489d-ce54-4140-83f6-b756f00b0967
Use it
Look up 43817-906 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43817-906 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43817-906. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.